Status:

UNKNOWN

Central Hemodynamics

Lead Sponsor:

Luzerner Kantonsspital

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Brief Summary

Guidelines recommend measuring end organ damage and in particular arterial stiffness in patients with hypertension. However, until now it was not possible to measure arterial stiffness with the use of...

Eligibility Criteria

Inclusion

  • Patients \>70 years (elderly cohort)
  • Patients with diabetes mellitus (diabetes cohort)
  • Patients with heart failure (heart failure cohort)
  • Patients with resistant hypertension (resistant hypertension cohort)

Exclusion

  • Patient refuses study participation
  • Severe renal failure
  • Reduced life expectancy

Key Trial Info

Start Date :

April 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01837784

Start Date

April 1 2013

Last Update

April 23 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Luzerner Kantonsspital

Lucerne, Canton of Lucerne, Switzerland, CH-6000

Central Hemodynamics | DecenTrialz